Reporting, Quality & Building an EndoFLIP Programme

A high-quality FLIP report has six fixed elements:

1. INDICATION + clinical context — one sentence stating why FLIP was performed. 2. HARDWARE — catheter model (EF-322N / EF-325N / EF-322B), balloon size, console software version. 3. TABULATED FILLS — CSA, pressure, and DI at 30, 40, 50, and 60 mL with the narrowest segment identified. 4. FLIP TOPOGRAPHY PATTERN — Normal RACs / Absent / RRC / Sustained occluding / Disordered. 5. INTEGRATED INTERPRETATION — quantitative DI versus published thresholds, cross-referenced with HRM if available, and Chicago v4.0 phenotype if applicable. 6. ACTIONABLE RECOMMENDATION — one of: supports achalasia, supports EGJ-OO, supports normal physiology, supports tight post-fundoplication, supports low-DI gastroparesis (G-POEM candidate), or inconclusive (pursue X).

Avoid free-text narrative-only reports — structured templates raise inter-reader agreement (kappa 0.85 vs 0.62 for free text in the Carlson 2021 inter-rater study) and feed downstream QA dashboards.

The SGA EndoFLIP Certification confirms an operator has reached independent-practice competence. The pathway has four stages:

STAGE 1 — Didactic completion: this 6-module course + a final 60-question MCQ exam, pass ≥ 80%.

STAGE 2 — Observed studies: 20 diagnostic FLIP cases observed and reviewed by a certified mentor; each case documented in the trainee logbook with the pre-FLIP differential, FLIP findings, and final clinical decision.

STAGE 3 — Intraoperative cases: 10 supervised intraoperative FLIP measurements during POEM, Heller, or fundoplication; the trainee must independently call the post-procedure DI within the validated target range in ≥ 8 of 10.

STAGE 4 — Therapeutic EsoFLIP: 5 supervised EsoFLIP dilations completed without major complication.

Maintenance of certification: 30 cases per year minimum, plus a one-day biennial refresher.

A FLIP programme without a quality dashboard is a programme that cannot improve. Track six metrics monthly:

• Case volume by indication (achalasia workup, post-fundo dysphagia, gastroparesis, intraoperative) • DI distribution histogram per indication • Concordance with HRM in same-session studies • Median report turnaround (target < 24 h) • Complication rate (mucosal tear, perforation, significant bleeding — target < 1%) • Patient-reported symptom change at 3 months post-therapy when FLIP was used to plan it (target ≥ 70% improvement)

Review the dashboard quarterly at the motility MDT and benchmark against published outcomes.

A successful programme has four building blocks:

• HARDWARE — EF-322N or EF-325N catheter, the EF-100 console, dedicated reporting station with the FLIP analysis software, and ideally an EsoFLIP catheter for therapeutic capacity.

• TRAINED OPERATORS — minimum one consultant motility specialist + one motility nurse per session. Plan for redundancy: at least two trained consultants to avoid single-point-of-failure.

• WORKFLOW INTEGRATION — FLIP referral built into the motility clinic pathway, linked with HRM and impedance-pH. Same-session FLIP-at-endoscopy slots offered to patients with borderline HRM. Theatre block bookings for intraoperative FLIP coordinated with the foregut surgical team.

• MULTIDISCIPLINARY GOVERNANCE — quarterly difficult-case review with surgery, radiology, and the foregut MDT. Annual benchmarking against published outcome metrics.

Plan for 3–4 sessions per week to maintain operator volume above the competence floor (30 cases/year).

For hospital administration, the FLIP business case turns on three lines:

CAPEX — EF-100 console (~ USD 25,000), 100 diagnostic catheters per year (~ USD 35,000), 20 EsoFLIP catheters (~ USD 30,000), reporting workstation and software (~ USD 5,000). Initial year one investment ~ USD 95,000.

REVENUE — at MOH and private-sector reimbursement levels, an EndoFLIP at endoscopy generates ~ USD 800–1,200; an intraoperative FLIP adds ~ USD 400 to the operative case fee; an EsoFLIP dilation reimburses ~ USD 2,500. A modest centre doing 200 diagnostic + 80 intraoperative + 30 EsoFLIP per year generates ~ USD 320,000 — payback in year one.

INTANGIBLE VALUE — shortened diagnostic pathway, reduced surgical revision, validated referral hub, training programme leverage, research output. The strategic ROI exceeds the financial.